Loading organizations...
§ Private Profile · 111 Da De Lu, Yue Xiu Qu, Guang Zhou Shi, Guang Dong Sheng, China, 510120
Investment firm focused on traditional Chinese medicine and health sectors.
Guangdong Traditional Chinese Medicine Health Fund is an entity described as an investment firm, yet specific details regarding its actual activities and operational headquarters are not publicly available. Comprehensive information concerning its core business model, target investment sectors, and primary customer base remains entirely undisclosed in all accessible public records. The fund has not reported any figures for assets under management, total funding raised, or any current valuation metrics, making its overall scale and financial scope exceptionally difficult to ascertain. Furthermore, no prominent lead investors, identifiable portfolio companies, or key customers associated with the fund have been publicly identified through any available channels or research. Comprehensive details concerning its founding year and the individuals responsible for its establishment are also not accessible through standard public information sources, thereby significantly limiting insight into its origins and leadership structure.
Guangdong Traditional Chinese Medicine Health Fund has raised $20.0M across 1 funding round.
The fund is managed by a collaborative effort between China Development Bank Financial and Guangdong Hengjian Holdings, combining their financial and investment expertise.
The fund has invested in companies such as Lion TCR, which is developing mRNA-encoding TCR T-cell therapy, and Jun Shengtai, contributing to its Series C funding round.
The fund is managed by a collaborative effort between China Development Bank Financial and Guangdong Hengjian Holdings, combining their financial and investment expertise.
The fund has invested in companies such as Lion TCR, which is developing mRNA-encoding TCR T-cell therapy, and Jun Shengtai, contributing to its Series C funding round.
Guangdong Traditional Chinese Medicine Health Fund has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Lion TCR - Series A in May 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 10, 2026 | Transcend Vivoscope | $14.5M Series B | — | Beijing Medical And Health Industry Investment Fund, Haikai Holdings Group, Tianjin Heying Haihe Brain Machine Fund, Zhongguancun Science City Science |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 29, 2018 | $20M Series A | — | Westlake Ventures Capital, Yashang Capital | Announced |
The Guangdong Traditional Chinese Medicine Health Fund is an investment vehicle structured to channel capital into the healthcare industry, with a specific emphasis on traditional Chinese medicine and related health technologies. Its operational management is a joint effort between China Development Bank Financial and Guangdong Hengjian Holdings, leveraging the expertise and resources of both entities in the financial and investment sectors.
The fund's investment strategy targets companies that are developing and commercializing advancements in healthcare. This includes enterprises engaged in biotechnology, pharmaceuticals, and other medical innovations. Its portfolio reflects an interest in emerging therapies and healthcare solutions that align with its core focus areas.
Notable investments by the Guangdong Traditional Chinese Medicine Health Fund include its participation in the Series B2 financing round for Lion TCR. This investment supported Lion TCR's work in developing mRNA-encoding TCR T-cell therapy, a cutting-edge approach to treating solid tumors. Such engagements highlight the fund's commitment to supporting innovative medical research and development.
Another key investment is in Jun Shengtai, where the fund contributed to the company's Series C funding round. These investments demonstrate the fund's active role in providing growth capital to companies at various stages of development within the healthcare and life sciences sectors.
The fund frequently collaborates with other investment institutions in its financing activities. It has forged partnerships with various esteemed investment institutions, including Jingwei, Nuclear Power High-Tech, PICC Capital Equity Investment, and Shenzhen Capital Group. These collaborations enable the fund to participate in larger and more complex investment rounds, broadening its impact within the venture ecosystem.
Through its strategic investments and partnerships, the Guangdong Traditional Chinese Medicine Health Fund aims to foster the growth of companies that contribute to the evolution of healthcare, particularly within the context of traditional Chinese medicine and modern medical science. Its involvement helps drive innovation and expand access to advanced healthcare solutions.